Wooree BIO

At a glance

Wooree BIO filed 32 disclosures in the last 12 months, including 1 insider and 1 5% holder. The most recent key filing was on Apr 7.

Revenue for 2025 was ₩1.04T, down 15.6% on 2024. Operating margin was 0.1% against 1.2% a year earlier. Debt was 192% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩586B and operating loss of ₩6.7B.

The 2025 annual report lists 95 employees with an average tenure of 2.5 years and average pay of ₩45.9M, #1619 of 1,829 listed companies by average pay. Its 9 directors and auditors were paid ₩92M each on average. It paid ₩20 per common share in cash dividends. 우리엔터프라이즈 and related parties held 33.99% at year end.

From the 2025 annual report

Staff: 95 (48 men, 47 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩4.4B. Directors and auditors: 9, paid ₩827M in total.

Dividends (common shares)

Largest shareholder

우리엔터프라이즈 holds 30.70%; with 2 related parties the group holds 33.99% of common shares at year end.

Auditor: 대성삼경회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary